Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
From The Lung To The Finger: An Unusual Presentation Of Adenosquamous Cell Carcinoma, Preeti Badve, Md, Sussy Obando Lara, Md, Elisenda Valdez Pena, Md, Myriah Magaris, Do, Zunaira Naeem, Md, Charalambos Solomides, Md, Avnish Bhatia
From The Lung To The Finger: An Unusual Presentation Of Adenosquamous Cell Carcinoma, Preeti Badve, Md, Sussy Obando Lara, Md, Elisenda Valdez Pena, Md, Myriah Magaris, Do, Zunaira Naeem, Md, Charalambos Solomides, Md, Avnish Bhatia
Department of Medical Oncology Posters
Learning Objective
To recognize unusual presentations of metastatic lung disease.
Development Of An Equitable, Interprofessional Medical Cannabis Education, Certification And Research Program In An Nci-Designated Cancer Center, Gregory Garber, Msw, Jillian Van Sciver, Mba, Denise Young, Msw, Latrisha Bentch, Ba, Bracken Babula, Md, Brooke Worster, Md
Development Of An Equitable, Interprofessional Medical Cannabis Education, Certification And Research Program In An Nci-Designated Cancer Center, Gregory Garber, Msw, Jillian Van Sciver, Mba, Denise Young, Msw, Latrisha Bentch, Ba, Bracken Babula, Md, Brooke Worster, Md
Department of Medical Oncology Posters
Background: Medical cannabis (MC), state-regulated cannabis programs accessible with a physician certification for a qualifying diagnosis, now exist in 47 states. Little attention has been paid to ensuring equitable access to such programs for the most vulnerable cancer patients.1 Estimates of cannabis use in cancer patients range from 30-40%2 yet access to MC is highly dependent on a number of variables including: geography, cost, availability of certifying providers, lack of provider education and a confusing array of state programs coupled with ongoing federal illegality. The historic criminalization of cannabis and the disproportionate impact on People of Color creates another …
Trial In Progress: Sonoporation For Disrupting The Pancreatic Cancer Microenvironment To Enhance Chemotherapy Delivery And Improve Outcomes, James Posey, John R. Eisenbrey, Babar Bashir, Patrick Mille, Atrayee Basu Mallick, Rajan Singla, Spiros Kotopoulis, Ingrid Nordaas, Audun Magerøy Trelsgård, Tæraneh Jouleh, Georg Dimcevski, Odd Helge Gilja, Flemming Forsberg
Trial In Progress: Sonoporation For Disrupting The Pancreatic Cancer Microenvironment To Enhance Chemotherapy Delivery And Improve Outcomes, James Posey, John R. Eisenbrey, Babar Bashir, Patrick Mille, Atrayee Basu Mallick, Rajan Singla, Spiros Kotopoulis, Ingrid Nordaas, Audun Magerøy Trelsgård, Tæraneh Jouleh, Georg Dimcevski, Odd Helge Gilja, Flemming Forsberg
Department of Medical Oncology Posters
Background
- Pancreatic ductal adenocarcinoma (PDAC) is 3% of cancers diagnosed in the United States with 62,210 new cases expected in 2022, but it is the fourth leading cause of cancer-related deaths.
- Hence, there is a considerable clinical need to develop innovative strategies for effective drug delivery and treatment monitoring, resulting in improved outcomes for patients with PDAC.
- Sonoporation is a novel method that can enhance the therapeutic efficacy of co-administered chemotherapy by localized contrastenhanced ultrasound imaging (CEUS) of gas-filled microbubbles (ultrasound contrast agent UCA), which temporarily changes the tumor vascular microenvironment by increasing leakage from angiogenic vessels through microstreaming, shockwaves …